Drug Binding Assays do not Reveal Specific Binding of Lacosamide to Collapsin Response Mediator Protein 2 (CRMP‐2)-Reference-Cited by-同舟云学术

Drug Binding Assays do not Reveal Specific Binding of Lacosamide to Collapsin Response Mediator Protein 2 (CRMP‐2)

Published:2012-06 Issue:6 Volume:18 Page:493-500
ISSN:1755-5930
Container-title:CNS Neuroscience & Therapeutics
language:en
Short-container-title:CNS Neuroscience & Therapeutics

Author:

Wolff Christian¹,Carrington Bruce²,Varrin‐Doyer Michel³,Vandendriessche Anne¹,Van der Perren Christy¹,Famelart Michel¹,Gillard Michel¹,Foerch Patrik¹,Rogemond Véronique⁴⁵⁶,Honnorat Jerôme⁴⁵⁶,Lawson Alastair²,Miller Karen¹

Affiliation:

1. UCB Pharma, CNS Research, Braine l’Alleud, Belgium

2. UCB Pharma, Structural Biology, Slough, UK

3. University of California San Francisco, Neurology, San Francisco, CA, USA

4. Lyon Neuroscience Research Center INSERM U1028/CNRS UMR 5292, Lyon, France

5. Hospices Civils de Lyon, Hôpital Neurologique, Centre de Référence Maladie Rare “Syndromes neurologiques Paranéoplasiques”, Bron, France

6. Université de Lyon – Université Claude Bernard Lyon 1, Lyon, France

Publisher

Wiley

Subject

Pharmacology (medical),Physiology (medical),Psychiatry and Mental health,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1755-5949.2012.00313.x

Reference21 articles.

1. 2008 VIMPAT® (lacosamide) Prescribing Information.UCB Inc. Smyrna GA US ).

2. 2008 VIMPAT® Summary of Product Characteristics for Lacosamide.UCB Pharma S.A. Belgium ).

3. The Investigational Anticonvulsant Lacosamide Selectively Enhances Slow Inactivation of Voltage-Gated Sodium Channels

4. Differential Block of Sensory Neuronal Voltage-Gated Sodium Channels by Lacosamide [(2R)-2-(Acetylamino)-N-benzyl-3-methoxypropanamide], Lidocaine, and Carbamazepine

5. Lacosamide: A Review of Preclinical Properties

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current advances in rodent drug-resistant temporal lobe epilepsy models: Hints from laboratory studies;Neurochemistry International;2024-03

2. Efficacy and tolerability of immediate switch from sodium channel blockers to Lacosamide;Epilepsy & Behavior;2023-08

3. The therapeutic effects of lacosamide on epilepsy-associated comorbidities;Frontiers in Neurology;2023-03-16

4. Efficacy of lacosamide in the treatment of non-convulsive seizure and non-convulsive status epilepticus in septic patients: a narrative review;Frontiers in Emergency Medicine;2022-05-08

5. The antiepileptic drug lacosamide and memory – A preclinial study;Epilepsy & Behavior;2021-12